How Fetal Surgery Works—and Why It Matters

Operating Before Birth

Surgeons today can operate on patients who have not yet been born. Fetal surgery—the practice of treating a developing baby while it is still inside the mother's uterus—has evolved from a radical experiment into an established medical discipline that gives thousands of families options that did not exist a generation ago.

The field addresses congenital conditions that, left untreated, would cause irreversible damage or death before a baby ever takes its first breath. Understanding how these procedures work sheds light on one of modern medicine's most remarkable frontiers.

A Brief History

The roots of fetal surgery stretch back to 1963, when a team in New Zealand performed the first recorded intervention on a human fetus—a simple blood transfusion guided by X-ray. The modern era began in the early 1980s at the University of California, San Francisco, where Dr. Michael Harrison pioneered open fetal surgery, operating directly on a fetus through an incision in the mother's uterus. Since then, the field has expanded dramatically, with specialized fetal surgery centers now operating in North America, Europe, and Asia.

How Surgeons Reach the Fetus

There are three main approaches, each suited to different conditions and levels of complexity:

• Ultrasound-guided procedures are the least invasive. A needle or catheter is inserted through the mother's abdomen under real-time ultrasound imaging. These are used for relatively straightforward interventions such as draining fluid from the fetal chest or performing blood transfusions.
• Fetoscopic surgery uses miniature cameras and instruments inserted through tiny incisions—often just 3 to 4 millimetres wide—in the uterus. Surgeons watch a video feed as they operate. This approach treats conditions like twin-to-twin transfusion syndrome, in which identical twins sharing a placenta receive dangerously unequal blood flow.
• Open fetal surgery is the most invasive. The surgeon makes an incision in the mother's abdomen and uterus, partially exposes the fetus, performs the repair, and then closes everything back up. The pregnancy continues, ideally for several more weeks. This is used for the most complex cases, including spina bifida repair.

Spina Bifida: The Landmark Case

No condition has shaped fetal surgery more than myelomeningocele, the most severe form of spina bifida. In this defect, the fetal spinal column fails to close, leaving the spinal cord exposed to amniotic fluid, which progressively damages nerves.

The landmark MOMS trial (Management of Myelomeningocele Study), published in the New England Journal of Medicine in 2011, proved that prenatal repair dramatically outperformed postnatal surgery. Among 183 patients, fetal surgery cut the need for a brain shunt from 82% to 44% and doubled the chance of independent walking at 30 months—42% versus 21% for babies repaired after birth.

The trade-off is significant: prenatal surgery carries a higher risk of preterm delivery, with babies arriving on average three weeks earlier than those treated after birth.

Other Conditions Treated in the Womb

Beyond spina bifida, fetal surgery addresses a growing list of conditions:

• Twin-to-twin transfusion syndrome (TTTS) — laser ablation of shared blood vessels via fetoscopy
• Congenital diaphragmatic hernia (CDH) — a balloon is placed in the fetal airway to promote lung growth
• Lower urinary tract obstruction — shunts drain blocked fetal bladders
• Sacrococcygeal teratoma — large tumors at the base of the spine that can cause heart failure

Risks and Limitations

Fetal surgery is never routine. Opening the uterus can trigger preterm labor, premature rupture of membranes, or placental complications. A systematic review found that open fetal surgery carries a roughly 21% rate of maternal complications, while fetoscopic procedures bring that down to about 6%. Every case involves a careful weighing of fetal benefit against maternal risk—an ethical calculus unique to this field.

The Next Frontier: Stem Cells

Researchers are now combining fetal surgery with regenerative medicine. A Phase 1 clinical trial at UC Davis, published in The Lancet in 2026, tested placing a patch of human placenta-derived stem cells over the exposed spinal cord during fetal spina bifida repair. The trial reported no safety concerns, no infections or abnormal tissue growth, and MRI scans confirmed that brain abnormalities linked to spina bifida were reversed in every treated patient.

If larger trials confirm these results, stem-cell-enhanced fetal surgery could move beyond simply closing a defect to actively regenerating damaged tissue—pushing the boundaries of what medicine can achieve before a child is even born.